{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T02:03:29Z","timestamp":1761789809401,"version":"3.41.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Chronic disseminated intravascular coagulation (DIC) associated with thoracic aortic aneurysm is characterized by enhanced fibrinolysis and is thought to be stable in the compensated\/asymptomatic stage, with few bleeding symptoms. However, DIC can lead to decompensated\/hemorrhagic stage disseminated intravascular coagulation, resulting in severe bleeding diathesis, and there is currently no established strategy for treatment of DIC in aortic aneurysms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 77-year-old woman underwent angiography and cardiac catheterization, before descending aortic replacement surgery. She developed DIC in postprocedure week 2 with extensive, uncontrollable massive subcutaneous hemorrhage.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Her acute-phase DIC score was 7 points, and the risk of mortality within 30\u200adays after surgery according to the JapanSCORE was estimated to be 33.6%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Therapy was a combination of recombinant human soluble thrombomodulin (rhTM) and an aortic stent-graft treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Short-term improvements were seen in both DIC and bleeding diathesis. The thoracic aortic aneurysm with severe DIC was eventually corrected by administration of rhTM.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>We report the use of rhTM as an effective, novel anticoagulant drug with anti-inflammatory activity for treating DIC with suppressed fibrinolysis, which is typically associated with sepsis. In patients with a high hemorrhagic diathesis, in whom preoperative control of DIC cannot be achieved with conventional anticoagulation and radical surgical repair cannot be performed, a combination of rhTM and endovascular therapy may be a powerful new treatment option.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025044","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T12:34:37Z","timestamp":1614774877000},"page":"e25044","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Preoperative disseminated intravascular coagulation complicated by thoracic aortic aneurysm treated using recombinant human soluble thrombomodulin"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3769-1063","authenticated-orcid":false,"given":"Yoshinori","family":"Tanigawa","sequence":"first","affiliation":[{"name":"Department of Anesthesiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimihide","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Saga Medical School Hospital, Faculty of Medicine, Saga University, Saga, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Saga Medical School Hospital, Faculty of Medicine, Saga University, Saga, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Nakagawachi","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Saga Medical School Hospital, Faculty of Medicine, Saga University, Saga, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Sakaguchi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"R1-20250612","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/archinte.1967.00290230160008","article-title":"Multiple coagulation defects in association with dissecting aneurysm","volume":"119","author":"Fine","year":"1967","journal-title":"Arch Intern Med"},{"key":"R2-20250612","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/archsurg.1983.01390110010002","article-title":"Preoperative disseminated intravascular coagulation associated with aortic aneurysms. A prospective study of 76 cases","volume":"118","author":"Fisher","year":"1983","journal-title":"Arch Surg"},{"key":"R3-20250612","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.thromres.2013.12.033","article-title":"Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation\u2014safety and efficacy in 1,032 patients with hematologic malignancy","volume":"133","author":"Asakura","year":"2014","journal-title":"Thromb Res"},{"key":"R4-20250612","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.thromres.2014.02.025","article-title":"Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort","volume":"133","author":"Matsushita","year":"2014","journal-title":"Thromb Res"},{"key":"R5-20250612","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.leukres.2012.08.012","article-title":"Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation","volume":"36","author":"Ikezoe","year":"2012","journal-title":"Leuk Res"},{"key":"R6-20250612","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/CCM.0000000000004426","article-title":"Effect of a recombinant human soluble thrombomodulin on baseline coagulation biomarker levels and mortality outcome in patients with sepsis-associated coagulopathy","volume":"48","author":"Levi","year":"2020","journal-title":"Crit Care Med"},{"key":"R7-20250612","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial","volume":"5","author":"Saito","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R8-20250612","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jth.12841","article-title":"Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis","volume":"13","author":"Yamakawa","year":"2015","journal-title":"J Thromb Haemost"},{"key":"R9-20250612","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/ATVBAHA.112.251157","article-title":"Thrombomodulin protects endothelial cells from a calcineurin inhibitor-induced cytotoxicity by upregulation of extracellular signal-regulated kinase\/myeloid leukemia cell-1 signaling","volume":"32","author":"Ikezoe","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R10-20250612","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/CCM.0b013e31828e9b03","article-title":"A randomized double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation","volume":"41","author":"Vincent","year":"2013","journal-title":"Crit Care Med"},{"key":"R11-20250612","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.CCM.0000202209.42491.38","article-title":"A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria","volume":"34","author":"Gando","year":"2006","journal-title":"Crit Care Med"},{"key":"R12-20250612","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1161\/CIRCULATIONAHA.107.756684","article-title":"Japan Cardiovascular Surgery Database Organization. Risk model of thoracic aortic surgery in 4707 cases from a nationwide single-race population through a web-based data entry system: the first report of 30-day and 30-day operative outcome risk models for thoracic aortic surgery","volume":"118","author":"Motomura","year":"2008","journal-title":"Circulation"},{"key":"R13-20250612","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2169\/internalmedicine.46.6155","article-title":"Subcutaneous injection of heparin calcium controls chronic disseminated intravascular coagulation associated with inoperable dissecting aortic aneurysm in an outpatient clinic","volume":"46","author":"Miyahara","year":"2007","journal-title":"Intern Med"},{"key":"R14-20250612","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/BF02286787","article-title":"Aortic aneurysm-induced disseminated intravascular coagulation","volume":"10","author":"Aboulafia","year":"1996","journal-title":"Ann Vasc Surg"},{"key":"R15-20250612","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/BF00311684","article-title":"Preoperative disseminated intravascular coagulation (DIC) associated with aortic aneurysm\u2014does it need to be corrected before surgery?","volume":"25","author":"Oba","year":"1995","journal-title":"Surg Today"},{"key":"R16-20250612","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2169\/internalmedicine.54.4942","article-title":"Use of rivaroxaban for the effective management of disseminated intravascular coagulation associated with abdominal aortic aneurysm","volume":"54","author":"Kawano","year":"2015","journal-title":"Intern Med"},{"key":"R17-20250612","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial","volume":"5","author":"Saito","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R18-20250612","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/MBC.0b013e32835510d6","article-title":"Intermittent administration of recombinant human soluble thrombomodulin successfully controlled chronic disseminated intravascular coagulation in a patient with dissecting aortic aneurysm on an outpatient basis","volume":"23","author":"Iyama","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R19-20250612","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MBC.0000000000000031","article-title":"The effect of recombinant human soluble thrombomodulin on disseminated intravascular coagulation in an abdominal aortic aneurysm","volume":"25","author":"Hoshina","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R20-20250612","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/096721090000800411","article-title":"Chronic disseminated intravascular coagulopathy cured by abdominal aortic aneurysm repair","volume":"8","author":"Rowlands","year":"2000","journal-title":"Cardiovasc Surg"},{"key":"R21-20250612","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1510\/icvts.2006.136507","article-title":"Impact of blood coagulation and fibrinolytic system changes on early and mid term clinical outcome in patients undergoing stent endografting surgery","volume":"5","author":"Monaco","year":"2006","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R22-20250612","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/ejvs.1999.0970","article-title":"Consumptive coagulopathy following endovascular stent repair of abdominal aortic aneurysm","volume":"19","author":"Cross","year":"2000","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R23-20250612","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0741-5214(02)75323-8","article-title":"Blood coagulation and fibrinolytic response after endovascular stent grafting of thoracic aorta","volume":"37","author":"Shimazaki","year":"2003","journal-title":"J Vasc Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:01:15Z","timestamp":1749754875000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025044"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025044","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"2020-12-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}